Published in J Pharm Sci on November 01, 1977
Chemical decay of an antibiotic inverts selection for resistance. Nat Chem Biol (2010) 1.80
Molecular cloning of two paralytogenic, temperature-sensitive mutants, ts1 and ts7, and the parental wild-type Moloney murine leukemia virus. J Virol (1985) 1.28
Replication of murine leukemia virus in heterologous cells: interaction between ecotropic and xenotropic viruses. Virology (1981) 1.22
The neurovirulent determinants of ts1, a paralytogenic mutant of Moloney murine leukemia virus TB, are localized in at least two functionally distinct regions of the genome. J Virol (1986) 1.22
ts1, a Paralytogenic mutant of Moloney murine leukemia virus TB, has an enhanced ability to replicate in the central nervous system and primary nerve cell culture. J Virol (1985) 1.21
The effect of interferon on de novo infection of Moloney murine leukemia virus. Cell (1977) 1.16
Serum albumin beads: an injectable, biodegradable system for the sustained release of drugs. Science (1981) 1.12
In-vitro and in-vivo studies of the diclofenac sodium controlled-release matrix tablets. J Pharm Pharmacol (1995) 1.12
Newcastle disease virus-infected splenocytes express the proopiomelanocortin gene. J Exp Med (1986) 1.10
Vascular tolerance to nitroglycerin and cyclic GMP generation in rat aortic smooth muscle. J Pharmacol Exp Ther (1982) 1.08
Site-directed mutagenesis of the codon for Ile-25 in gPr80env alters the neurovirulence of ts1, a mutant of Moloney murine leukemia virus TB. J Virol (1990) 1.08
The influence of cosolvents on the in-vitro percutaneous penetration of diclofenac sodium from a gel system. J Pharm Pharmacol (1994) 1.07
Restriction of Moloney murine leukemia virus replication in Moloney murine sarcoma virus-infected cells. Virology (1984) 1.06
Tight binding affinities determined from thermodynamic linkage to protons by titration calorimetry. Methods Enzymol (1995) 1.02
Induction of syncytia by Moloney murine leukemia virus in myoblasts defective in differentiation. J Virol (1977) 0.99
Mechanism of murine leukemia virus-induced fusion in rat myoblasts defective in differentiation. J Virol (1977) 0.99
Murine retrovirus-induced depletion of T cells is mediated through activation-induced death by apoptosis. J Virol (1994) 0.98
A morphological study on the ultrastructure and assembly of murine leukemia virus using a temperature-sensitive mutant restricted in assembly. Virology (1977) 0.98
ts1, a mutant of Moloney murine leukemia virus-TB, causes both immunodeficiency and neurologic disorders in BALB/c mice. Virology (1989) 0.97
Moloney murine sarcoma virus 349 induces Kaposi's sarcomalike lesions in Balb/c mice. Am J Pathol (1990) 0.93
Circular dichroism and solution conformation of the tetracycline antibiotics. Tetrahedron Lett (1968) 0.92
Interaction of various tetracyclines with metallic cations in aqueous solutions as measured by by circular dichroism. Antimicrob Agents Chemother (Bethesda) (1969) 0.91
Binding of quinidine to plasma proteins in normal subjects and in patients with hyperlipoproteinemias. Clin Pharmacol Ther (1978) 0.91
Establishment and characterization of conditionally immortalized astrocytes to study their interaction with ts1, a neuropathogenic mutant of Moloney murine leukemia virus. J Neurovirol (1997) 0.89
Entrapment of bioactive compounds within native albumin beads: II. Effects of rate and extent of crosslinking on microbead properties. J Parenter Sci Technol (1987) 0.87
Circular dichroism and solution conformation of the tetracycline antibiotics. Antimicrob Agents Chemother (Bethesda) (1968) 0.87
Characterization of Moloney murine leukemia and sarcoma viruses separated by isokinetic gradient centrifugation. Virology (1980) 0.86
Isolation and characterization of a Mo-MuSV-transformed TB cell line that produces noninfectious MuSV particles with uncleaved gag protein which is processed in the presence of Mo-MuLV. Virology (1984) 0.84
Metabolic reduction of naltrexone. I. Synthesis, separation and characterization of naloxone and naltrexone reduction products and qualitative assay of urine and bile following administration of naltrexone, alpha-naltrexol, or beta-naltrexol. Res Commun Chem Pathol Pharmacol (1975) 0.83
Construction and characterization of expression systems for the env gene of ts1, a mutant of Moloney murine leukemia virus-TB. Virus Res (1991) 0.83
Electron microscopic characterization of the defectiveness of a temperature-sensitive mutant of Moloney murine leukemia virus restricted in assembly. J Virol (1977) 0.82
Kinetics of dehydration of epitetracycline in solution. J Pharm Sci (1974) 0.82
Use of the 295- to 300-nanometer circular dichroism through of ribonucleic acid to study helix winding: effect of acridine orange. Antimicrob Agents Chemother (1973) 0.82
Evaluation of antiproliferative agents using a cell-culture model. Invest Ophthalmol Vis Sci (1990) 0.81
A single mutation in one of the CORE elements of Moloney murine leukemia virus reduced binding of a 42-kDa T lymphoma cell nuclear factor but did not affect lymphomagenesis. Mol Carcinog (1990) 0.81
Loss of nitroglycerin from aqueous solution into plastic intravenous delivery systems. J Pharm Sci (1979) 0.81
Cell types in the central nervous system infected by murine retroviruses: implications for the mechanisms of neurodegeneration. Histol Histopathol (1994) 0.79
Nitroglycerin tolerance and cyclic GMP generation in the longitudinal smooth muscle of the guinea-pig ileum. J Pharmacol Exp Ther (1983) 0.79
Topical ocular hypotensive effects of the novel angiotensin converting enzyme inhibitor SCH 33861 in conscious rabbits. J Ocul Pharmacol (1987) 0.78
Stability of nitroglycerin injection determined by gas chromatography. Am J Hosp Pharm (1978) 0.77
Binding of dopaminergic drugs by the neuromelanin of the substantia nigra, synthetic melanins and melanin granules. Fed Proc (1978) 0.77
Second derivative infrared spectroscopy as a non-destructive tool to assess the purity and structural integrity of proteins. Pharm Res (1995) 0.77
Effect of inert tablet ingredients on drug absorption. I. Effect of polyethylene glycol 4000 on the intestinal absorption of four barbiturates. J Pharm Sci (1966) 0.76
Long-term cultivation and productive infection of primary thymocyte cultures by a thymocytopathic murine retrovirus. Virology (1996) 0.76
Tritiated naltrexone binding in plasma from several species and tissue distribution in mice. J Pharm Sci (1976) 0.76
Circular dichroism measurements of the tetracyclines. IV. 5-Hydroxylated derivatives. Antimicrob Agents Chemother (1972) 0.75
Prediction of xanthine solubilities using statistical techniques. J Pharm Sci (1985) 0.75
Use of circular dichroism in analysis of mixtures of tetracycline and 4-epitetracycline and its application to assay of commercial products. J Pharm Sci (1973) 0.75
Stability of thiamine hydrochloride repackaged in disposable syringes. Am J Hosp Pharm (1982) 0.75
Entrapment of bioactive compounds within native albumin beads: III. Evaluation of parameters affecting drug release. J Parenter Sci Technol (1987) 0.75
Compatibility and stability of labetalol hydrochloride in commonly used intravenous solutions. Am J Hosp Pharm (1983) 0.75
Drug release from glutaraldehyde-treated fibrin gels. Drug Des Deliv (1990) 0.75
Methods for the quantitation of nitroglycerin and its metabolites in human plasma. J Chromatogr (1982) 0.75
Kinetics of calcium carbonate neutralization. First-order case of the cube-root law. J Pharm Sci (1965) 0.75
Prediction of solubility in nonideal multicomponent systems using the UNIFAC group contribution model. J Pharm Sci (1985) 0.75
Prolongation of drug release by covalent bonding of drugs to serum albumin microbeads. Drug Des Deliv (1991) 0.75
Competitive binding between cocaine and various drugs to synthetic levodopa melanin. J Pharm Sci (1977) 0.75
Kinetics of the efflux of 3H-norepinephrine from rabbit irides. Naunyn Schmiedebergs Arch Pharmacol (1984) 0.75
Interaction of nitroglycerin with human blood components. J Pharm Sci (1983) 0.75
The postulated lymphoid-adrenal axis. A molecular approach. Ann N Y Acad Sci (1987) 0.75
Pharmacologic implications of alpha-adrenoreceptor interactive parameters for epinephrine enantiomers in the rat vas deferens. Chirality (1989) 0.75
Electron microscopical studies on Ditylenchus dipsaci (Kühn). I. Stomatal region. Can J Zool (1967) 0.75
Rate and proposed mechanism of anhydrotetracycline epimerization in acid solution. J Pharm Sci (1977) 0.75
Studies on the in-vitro percutaneous penetration of indomethacin from gel systems in hairless mice. J Pharm Pharmacol (1995) 0.75
A chiroptical study of penicillins. J Antibiot (Tokyo) (1974) 0.75
Studies on the pathology, especially brain hemorrhage and angioendotheliomas, induced by two new mos-containing viruses. J Neurovirol (2000) 0.75
Calorimetric determination of the heat of precipitation of pseudoephedrine racemic compound--its agreement with the heat of solution. J Pharm Sci (1995) 0.75
Dielectric analysis in the characterization of amorphous pharmaceutical solids. 1. Molecular mobility in poly(vinylpyrrolidone)-water systems in the glassy state. J Pharm Sci (1995) 0.75
Circular dichroism studies of aryl diasteroisomers. 3. Cupra A spectra of chloramphenicol derivatives. J Med Chem (1973) 0.75
Quantitative characterization of adsorption isotherms using isothermal microcalorimetry. J Pharm Sci (1996) 0.75
Steady-state and nonsteady-state transport through membranes using rotating-disk electrode polarography: description and properties of a rapid response new technique. J Pharm Sci (1973) 0.75
Use of 2-(4'-hydroxybenzeneazo)benzoic acid to study the binding of L-thyroxine to serum albumins. J Pharm Sci (1974) 0.75
Influence of cardiopulmonary bypass on nitroglycerin clearance. J Clin Pharmacol (1986) 0.75
Nitroglycerin stability: effects on bioavailability, assay and biological distribution. J Clin Hosp Pharm (1981) 0.75
Fibrin based drug delivery systems. J Parenter Sci Technol (1991) 0.75
Determination of protein binding parameters in systems involving interaction between sites. J Pharm Sci (1975) 0.75
Circular dichroism studies of aryl diastereoisomers. 2. Dependence of 1 L b transition sign upon the nature of the para substituent in various chloramphenicol derivatives. J Med Chem (1973) 0.75
Entrapment of bioactive compounds within native albumin beads. J Parenter Sci Technol (1983) 0.75
Loss of nitroglycerin to pulmonary artery delivery systems. Am J Hosp Pharm (1983) 0.75
Characterization of a continuous lymphocyte cell line derived from BALB/c mice inoculated with a recombinant Moloney murine leukemia virus-TB. Indian J Exp Biol (1992) 0.75